Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

February 17, 2026 7:00am EST

ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:

Raymond James 47th Annual Institutional Investors Conference Participation: Presentation and 1x1 investor meetings Date/Time: Presentation Tuesday, March 3, 2026, 3:25 PM ET Webcast Link: Raymond James/Axogen Presentation

Leerink Global Healthcare Conference Participation: Fireside Chat and 1x1 investor meetings Date/Time: Fireside Chat Monday, March 9, 2026, 1:00 PM ET Webcast Link: Leerink/Axogen Fireside Chat

The Citizens Life Sciences Conference Participation: Fireside Chat and 1x1 investor meetings Date/Time: Fireside Chat Tuesday, March 10, 2026, 12:30 PM ET Webcast Link: Citizens/Axogen Fireside Chat

Webcast events can be accessed live through the Investors page at www.axogeninc.com . For those unable to listen to the live broadcast, the replay will be archived for 90 days and available on the Investors page at www.axogeninc.com .

About Axogen

Axogen (Nasdaq: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, Axogen advances the field through research, education, and collaboration with surgeons and healthcare providers across a global network.

Axogen’s product portfolio includes Avance® (acellular nerve allograft-arwx), Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™.​

Contact: Axogen, Inc. InvestorRelations@axogeninc.com

Source: Axogen, Inc. Released February 17, 2026